The global supply of COVID-19 vaccines remains limited. An understanding of the immune
response that is predictive of protection could facilitate rapid licensure of new vaccines. Data …

Background The ChAdOx1 nCoV-19 (AZD1222) vaccine has been approved for emergency
use by the UK regulatory authority, Medicines and Healthcare products Regulatory Agency, …

Background A new variant of SARS-CoV-2, B.1.1.7, emerged as the dominant cause of
COVID-19 disease in the UK from November, 2020. We report a post-hoc analysis of the efficacy …

Objectives The conventional dissolution test, particularly the USP apparatus I and II, remains
an important tool in the armory of the pharmaceutical development scientist. For realistic …

The potential to fine-tune the transition temperatures of polymers displaying lower-critical
solution temperatures (LCST) by a simple mixing strategy is investigated. Using a panel of four …

Antimicrobial resistance is a global healthcare problem with a dwindling arsenal of usable
drugs. Tuberculosis, caused by Mycobacterium tuberculosis, requires long-term combination …

Significance: The development of responsive drug delivery systems (DDS) holds great
promise as a tool for improving the pharmacokinetic properties of drug compounds. Redox-…

The application of synthetic glycopolymers to anti-adhesive therapies has so far been limited
by their lack of lectin specificity. Here we employ a macromolecular engineering approach …

Disulfide linkages were introduced into poly (N-isopropylacrylamide) by the polycondensation
of a RAFT-derived, telechelic macromonomer to give degradable yet vinyl-based polymers…

Telechelic, RAFT (reversible addition–fragmentation chain transfer)-derived macromonomers
with a pyridyl disulfide end-group were converted into high molecular weight, disulfide-…